Imagin Medical Inc C.IME

Alternate Symbol(s): IMEXF

Imagin Medical Inc. is a urologic oncology company. It is engaged in developing technologies to better visualize and treat urologic cancers through minimally invasive surgery, including bladder and prostate cancer. Its first product, enCAGE Coil, is designed to eliminate the limitations of other methods of prostate cancer treatment that can cause erectile dysfunction and urinary incontinence. The device is a disposable, focal therapy, precision ablation system that will deliver bipolar, radio frequency energy through a distinctive coil electrode, or cage. It enables the surgeon to preset margins for precise tissue targeting. Its second product, the i/Blue Imaging System, will bring several key technological advancements that improve the utility of blue light imaging for visualizing bladder cancer. The i/Blue System delivers blue light imaging technology in a more versatile, practical, and accessible format and is designed to work with existing fiberoptic endoscopes on the market.

CSE:IME - Post by User

Imagin Medical Inc

Bullboard Posts

Comment by Papertiger73on Jun 03, 2019 12:24pm

104 Views

Post# 29794240

RE:IME Key Date

They are really streching out the reporting for a do nothing quarter that ended in March.

It only took them 8 weeks to get the results out for the 1st quarter, now it is taking them 10 weeks to put out Q2.

This leads me to believe that either:

A) Bad results on the way, so they are pushing it off as far as they can

B) Trying to negotiate a deal/awaiting news from FDA

Hoping it is the latter, but would imagine it is the former.

I am far from the shallows now.

Cause I am in too deep, and I am trying to keep my Up above in my head, instead of going under (too late for that)

Bullboard Posts

How one company is disrupting PoC testing